Ryan Sessums, MD
Pulmonary Disease · Tupelo, MSNPI 1487115655
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (56.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 81.8% of it on its own, with 15 other manufacturers making up the rest. That places this record below the midpoint for pulmonary disease clinicians in MS, where the typical reported total is $4,861.
Across 43 payments — averaging $103.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$4K
- AstraZeneca$179
- GSK$89
- Regeneron Healthcare Solutions, Inc.$77
- Baxter Healthcare$63
- Insmed, Inc.$55
- plus $342 from 10 others
What the payments were for
- Travel & lodging$1,10925%
- Food & beverage$82119%
- Education$2,50056%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $3,626 |
| AstraZeneca | 7 | $179 |
| GSK | 5 | $89 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| Baxter Healthcare | 3 | $63 |
| Insmed, Inc. | 3 | $55 |
| Grifols USA, LLC | 2 | $52 |
| Jazz Pharmaceuticals Inc. | 2 | $49 |
| Merck | 2 | $43 |
| Actelion Pharmaceuticals US, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $39 |
| Boehringer Ingelheim | 2 | $35 |
| Viatris Specialty LLC | 1 | $32 |
| Fisher & Paykel Healthcare Inc | 1 | $18 |
| Sanofi | 1 | $17 |
| Amgen | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,579
How this compares
$4,431 in reported general payments places this provider in the 45th percentile of 101 pulmonary disease providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,976 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $9,757 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $3,885 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $427 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $89 | $25,61850 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 101 pulmonary disease providers in Mississippi.
Other pulmonary disease in Tupelo
- Jaime UngoTupelo$29K
- William EdmonsonTupelo$15K
- Paul PerryTupelo$13K
- Kevin HarbourTupelo$13K
- Robert StewartTupelo$10K
- David WittyTupelo$7K
- Jose Henao CorreaTupelo$4K
- William FrazierCanton$809K
- Demondes HaynesJackson$809K
- Bobby TullosGulfport$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.